Microsoft beats Wall Street expectations, shares soar on robust Azure growth Markets Microsoft outpaced expectations for its third-quarter revenue and profit, unveiled on Thursday. This success was largely fueled by the integration of artificial intelligence (AI) across its cloud services, propelling its shares to surge by more than 4 per cent during extended trading.
British Patient Capital invests over £40m to boost UK cyber security firms Tech The UK's cyber security industry is currently in high demand due to a rise in attacks, especially on businesses and high-income charities.
Pinewood Technologies pivots to software after sale of legacy Pendragon business Tech On Thursday, Pinewood reported revenue of £24.5m from its software unit.
Focusrite: Music software company hits flat note as revenue falls £11m April 25, 2024 Focusrite's net debt more than doubled to £27.3m in the first half of the year, which it blamed on higher working capital levels.
Investors in London-listed medical tech firm continue battle to oust top brass April 24, 2024 Investors in a London-listed medical technology firm are continuing their campaign to oust the company’s top brass as its share price languishes.
FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences April 24, 2024 | Sponsored Dubai, 23 April 2024: For the second consecutive year, Dubai will remain in the spotlight as it hosts the second edition of Dubai FinTech Summit, under the patronage of His Highness Sheikh Maktoum bin Mohammed bin Rashid Al Maktoum, First Deputy Ruler of Dubai, Deputy Prime Minister, and Minister of Finance of the UAE and [...]
Regulator launches three investigations into Microsoft and Amazon April 24, 2024 The CMA is worried that big tech partnerships could give the likes of Microsoft and Amazon too much market power and harm competition.
National security is an ‘arms race’ says boss of chip designer Arm April 24, 2024 The chief architect at Arm said although national infrastructure is improving, there is a "tremendous amount" that needs to be done.
US regulator accepts GSK’s application to expand treatment of cancer drug April 24, 2024 The treatment, Jemperli, will now be classed as being able to help all adult patients with primary advanced or recurrent endometrial cancer. It is used alongside chemotherapy.
Angle agrees deal with Astrazeneca for tech to kill cancer cells April 24, 2024 This is expected to be driven by an increase in the use of combination therapy for the treatment of drug-resistant cancers and the need for novel targeted medicines for cancer treatment.